Virtual Medicinal Product (VMP) - Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules Start Date 21-06-2004 End Date
Previous Name Previous Name Neostigmine 2.5mg/ml / Glycopyrronium bromide 500micrograms/ml injection 1ml ampoules Start Date 23-06-2003 End Date 20-06-2004
Abbreviated Name Abbreviated Name Neostigmine 2.5mg/Glycopyrronium brom 500microg/1ml inj amp Start Date 13-09-2004
Previous Abbreviated Name Neostigmine 2.5mg/Glycopyrronium brom 500microg/1ml soln inj Previous Start Date 21-06-2004 Previous End Date 12-09-2004

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Solution for injection
Ontology Form/Route
solutioninjection.intravenous
Name Basis
Other

Codes

ATC Code
N07AA51
BNF Start Date End Date
Current BNF 15010600 Start Date 04-04-2022 End Date
Previous BNF 15010600 Start Date 23-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36030711000001107 29-10-2018
334084002 20-06-2003 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Glycopyrronium bromide Based on Ingredient Substance 500 microgram 1 ml
Neostigmine metilsulfate Based on Ingredient Substance 2.5 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
10 ampoule